These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 23908591)

  • 41. CTCF and EGR1 suppress breast cancer cell migration through transcriptional control of Nm23-H1.
    Wong KM; Song J; Wong YH
    Sci Rep; 2021 Jan; 11(1):491. PubMed ID: 33436746
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells.
    Steiner LA; Schulz V; Makismova Y; Lezon-Geyda K; Gallagher PG
    PLoS One; 2016; 11(5):e0155378. PubMed ID: 27219007
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sp1 is necessary for gene activation of Adamts17 by estrogen.
    Jia Z; Gao S; M'Rabet N; De Geyter C; Zhang H
    J Cell Biochem; 2014 Oct; 115(10):1829-39. PubMed ID: 24906090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differential DNA methylation and CTCF binding between the ESR1 promoter a of MCF-7 and MDA-MB-231 breast cancer cells.
    Montes-de-Oca-Fuentes EV; Jácome-López K; Zarco-Mendoza A; Guerrero G; Ventura-Gallegos JL; Juárez-Méndez S; Cabrera-Quintero AJ; Recillas-Targa F; Zentella-Dehesa A
    Mol Biol Rep; 2024 Jan; 51(1):148. PubMed ID: 38236307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The siRNA-mediated silencing of Bmi-1 promotes apoptosis and inhibits invasion of MCF-7 breast cancer cells].
    Deng X; Wu X; Weng H; Song F
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1036-40. PubMed ID: 27412932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The C-terminus of interferon gamma receptor beta chain (IFNgammaR2) has antiapoptotic activity as a Bax inhibitor.
    Gomez JA; Sun W; Gama V; Hajkova D; Yoshida T; Wu Z; Miyagi M; Pink JJ; Jackson MW; Danielpour D; Matsuyama S
    Cancer Biol Ther; 2009 Sep; 8(18):1771-86. PubMed ID: 19657228
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Role of CTCF in Regulating SLC45A3-ELK4 Chimeric RNA.
    Qin F; Song Y; Zhang Y; Facemire L; Frierson H; Li H
    PLoS One; 2016; 11(3):e0150382. PubMed ID: 26938874
    [TBL] [Abstract][Full Text] [Related]  

  • 48. EGR-1 forms a complex with YAP-1 and upregulates Bax expression in irradiated prostate carcinoma cells.
    Zagurovskaya M; Shareef MM; Das A; Reeves A; Gupta S; Sudol M; Bedford MT; Prichard J; Mohiuddin M; Ahmed MM
    Oncogene; 2009 Feb; 28(8):1121-31. PubMed ID: 19137013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gene-specific repression of the p53 target gene PUMA via intragenic CTCF-Cohesin binding.
    Gomes NP; Espinosa JM
    Genes Dev; 2010 May; 24(10):1022-34. PubMed ID: 20478995
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The cancer-testis antigen BORIS phenocopies the tumor suppressor CTCF in normal and neoplastic cells.
    Tiffen JC; Bailey CG; Marshall AD; Metierre C; Feng Y; Wang Q; Watson SL; Holst J; Rasko JE
    Int J Cancer; 2013 Oct; 133(7):1603-13. PubMed ID: 23553099
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNAi-independent role for Argonaute2 in CTCF/CP190 chromatin insulator function.
    Moshkovich N; Nisha P; Boyle PJ; Thompson BA; Dale RK; Lei EP
    Genes Dev; 2011 Aug; 25(16):1686-701. PubMed ID: 21852534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-Myc overexpression sensitizes Bim-mediated Bax activation for apoptosis induced by histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through regulating Bcl-2/Bcl-xL expression.
    Jiang X; Tsang YH; Yu Q
    Int J Biochem Cell Biol; 2007; 39(5):1016-25. PubMed ID: 17331788
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcriptional repression of AIB1 by FoxG1 leads to apoptosis in breast cancer cells.
    Li JV; Chien CD; Garee JP; Xu J; Wellstein A; Riegel AT
    Mol Endocrinol; 2013 Jul; 27(7):1113-27. PubMed ID: 23660594
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Depletion of CTCF in Breast Cancer Cells Selectively Induces Cancer Cell Death via p53.
    Lee JY; Mustafa M; Kim CY; Kim MH
    J Cancer; 2017; 8(11):2124-2131. PubMed ID: 28819414
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epigenetic silencing of miR-181c by DNA methylation in glioblastoma cell lines.
    Ayala-Ortega E; Arzate-Mejía R; Pérez-Molina R; González-Buendía E; Meier K; Guerrero G; Recillas-Targa F
    BMC Cancer; 2016 Mar; 16():226. PubMed ID: 26983574
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Maximum growth and survival of estrogen receptor-alpha positive breast cancer cells requires the Sin3A transcriptional repressor.
    Ellison-Zelski SJ; Alarid ET
    Mol Cancer; 2010 Sep; 9():263. PubMed ID: 20920219
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A widely expressed transcription factor with multiple DNA sequence specificity, CTCF, is localized at chromosome segment 16q22.1 within one of the smallest regions of overlap for common deletions in breast and prostate cancers.
    Filippova GN; Lindblom A; Meincke LJ; Klenova EM; Neiman PE; Collins SJ; Doggett NA; Lobanenkov VV
    Genes Chromosomes Cancer; 1998 May; 22(1):26-36. PubMed ID: 9591631
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Silencing of human phosphatidylethanolamine-binding protein 4 sensitizes breast cancer cells to tumor necrosis factor-alpha-induced apoptosis and cell growth arrest.
    Wang X; Li N; Li H; Liu B; Qiu J; Chen T; Cao X
    Clin Cancer Res; 2005 Oct; 11(20):7545-53. PubMed ID: 16243830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CTCF-Mediated Enhancer-Promoter Interaction Is a Critical Regulator of Cell-to-Cell Variation of Gene Expression.
    Ren G; Jin W; Cui K; Rodrigez J; Hu G; Zhang Z; Larson DR; Zhao K
    Mol Cell; 2017 Sep; 67(6):1049-1058.e6. PubMed ID: 28938092
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epigenetic boundaries of tumour suppressor gene promoters: the CTCF connection and its role in carcinogenesis.
    Recillas-Targa F; De La Rosa-Velázquez IA; Soto-Reyes E; Benítez-Bribiesca L
    J Cell Mol Med; 2006; 10(3):554-68. PubMed ID: 16989720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.